ABSTRACT
OBJECTIVE: Cannabis use is common among individuals with opioid use disorder, but it remains unclear whether cannabis use is associated with an increase or a reduction in illicit opioid use. To overcome limitations identified in previous longitudinal studies with limited follow-ups, the authors examined a within-person reciprocal relationship between cannabis and heroin use at several follow-ups over 18 to 20 years. METHODS: The Australian Treatment Outcome Study (ATOS) recruited 615 people with heroin dependence in 2001 and 2002 and reinterviewed them at 3, 12, 24, and 36 months as well as 11 and 18-20 years after baseline. Heroin and cannabis use were assessed at each time point using the Opiate Treatment Index. A random-intercept cross-lagged panel model analysis was conducted to identify within-person relationships between cannabis use and heroin use at subsequent follow-ups. RESULTS: After accounting for a range of demographic variables, other substance use, and mental and physical health measures, an increase in cannabis use 24 months after baseline was significantly associated with an increase in heroin use at 36 months (estimate=0.21, SE=0.10). Additionally, an increase in heroin use at 3 months and 24 months was significantly associated with a decrease in cannabis use at 12 months (estimate=-0.27, SE=0.09) and 36 months (estimate=-0.22, SE=0.08). All other cross-lagged associations were not significant. CONCLUSIONS: Although there was some evidence of a significant relationship between cannabis and heroin use at earlier follow-ups, this was sparse and inconsistent across time points. Overall, there was insufficient evidence to suggest a unidirectional or bidirectional relationship between the use of these substances.
Subject(s)
Cannabis , Hallucinogens , Heroin Dependence , Opioid-Related Disorders , Humans , Heroin/therapeutic use , Follow-Up Studies , Australia/epidemiology , Treatment Outcome , Heroin Dependence/epidemiology , Opioid-Related Disorders/drug therapy , Hallucinogens/therapeutic useABSTRACT
BACKGROUND: Epidemiological data from Mexico have documented an increase in heroin use in the last decade. However, there is no comprehensive care strategy for heroin users, especially those who have been accused of a crime. The objective of this study was to describe the heroin and methadone use of intravenous heroin users of both sexes who have been in jail, to offer evidence for the formulation of health policy. METHODS: This study used an ethnographic approach, with open-ended interviews carried out from 2014 to the present. Heroin users of both sexes attending a private methadone clinic in Mexico City were invited to participate. The sample was non-probabilistic. All interviews were audiotaped and transcribed, and narratives were analyzed using thematic analysis. RESULTS: Participants in this study were 33 users of heroin, two of them women, who had been in prison. They ranged in age from 33 to 62 years, had used heroin for a period of 13-30 years, and were from three states: Michoacan, Oaxaca, and Mexico City. Three principal categories of analysis were structured: 1. Pilgrimage for help (dynamics of the drama of suffering, pain, and time through health care spaces); 2) methadone use as self-care; and 3) accessibility to methadone treatment. The impossibility of access to methadone treatment is a condition which motivates users in their journey. The dynamics of methadone use are interpreted as a form of self-care and care to avoid substance use. Reducing the psychological, physical, and harmful effects of the substance allows them to perform daily activities. The inability to access treatment leads to a significant effect on users who experience structural violence. CONCLUSION: Compassionate methadone treatment and holistic attention should be considered as a way to meet patients' needs and mitigate their suffering, based on public health policy that allows for human rights-based care.
Subject(s)
Compassionate Use Trials , Heroin Dependence , Adult , Female , Heroin Dependence/drug therapy , Heroin Dependence/epidemiology , Heroin Dependence/psychology , Humans , Male , Methadone/therapeutic use , Mexico/epidemiology , Middle Aged , ViolenceABSTRACT
BACKGROUND: Opioid prescribing guidelines recommend reducing or discontinuing opioids for chronic pain if harms of opioid treatment outweigh benefits. As opioid discontinuation becomes more prevalent, it is important to understand whether opioid discontinuation is associated with heroin use. In this study, we sought to assess the association between opioid discontinuation and heroin use documented in the medical record. METHODS: A matched nested case-control study was conducted in an integrated health plan and delivery system in Colorado. Patients receiving opioid therapy in the study period (January 2006-June 2018) were included. Opioid discontinuation was defined as ≥45 days with no opioids dispensed after initiating opioid therapy. The heroin use onset date represented the index date. Case patients were matched to up to 20 randomly selected patients without heroin use (control patients) by age, sex, calendar time, and time between initiating opioid therapy and the index date. Conditional logistic regression models estimated matched odds ratios (mOR) for the association between an opioid discontinuation prior to the index date and heroin use. RESULTS: Among 22,962 patients prescribed opioid therapy, 125 patients (0.54%) used heroin after initiating opioid therapy, of which 74 met criteria for inclusion in the analysis. The odds of opioid discontinuation were approximately two times higher in case patients (n = 74) than control patients (n = 1045; mOR = 2.19; 95% CI 1.27-3.78). CONCLUSIONS: Among patients prescribed chronic opioid therapy, the observed increased risk for heroin use associated with opioid discontinuation should be balanced with potential benefits.
Subject(s)
Analgesics, Opioid/adverse effects , Chronic Pain/drug therapy , Chronic Pain/epidemiology , Heroin Dependence/epidemiology , Heroin/adverse effects , Withholding Treatment/trends , Adult , Aged , Analgesics, Opioid/administration & dosage , Case-Control Studies , Chronic Pain/psychology , Cohort Studies , Colorado/epidemiology , Female , Heroin Dependence/diagnosis , Heroin Dependence/psychology , Humans , Male , Middle Aged , Practice Patterns, Physicians'/trends , Risk FactorsABSTRACT
Drug use, including opioid use disorder, is one of the rapidly rising and serious problems affecting populations globally. There is a treatment gap and delay in presentation of drug users to treatment centers. The present study aimed at assessing the pathways to care among opioid-dependent individuals seeking treatment from a community-based treatment center in India. In a cross-sectional observational study conducted at a community clinic of the National Drug Dependence Treatment Centre (NDDTC), New Delhi, India, a total of 100 treatment-seeking drug users (age 18-60 years) fulfilling DSM IV TR criteria for opioid dependence were recruited. The data were collected using a semistructured pro forma based on patient self-report and the encounter form used in the World Health Organization (WHO) Pathway Study. All participants were male, were mostly married, were employed, and belonged to nuclear families. Ninety-eight percent of participants has ever used heroin in a dependent fashion and 20% were using it currently. Mean age of the participants was 40.83 years (SD 12.7). Median age of onset of heroin use was 22 years (IQR 12). Median duration of heroin use was 138 months (IQR 132). Only 21% of participants visited the community deaddiction clinic at the first contact with care. The median time for first treatment-seeking attempt was 9.5 years (IQR 7). The study findings suggest significant delay between onset of drug-related problems and first treatment contact. There is a need to increase the availability and accessibility of treatment services to reduce the delay in treatment seeking.
Subject(s)
Community Health Services/statistics & numerical data , Opioid-Related Disorders/epidemiology , Opioid-Related Disorders/therapy , Patient Acceptance of Health Care/statistics & numerical data , Substance Abuse Treatment Centers/statistics & numerical data , Time-to-Treatment/statistics & numerical data , Adolescent , Adult , Age of Onset , Critical Pathways , Cross-Sectional Studies , Heroin Dependence/epidemiology , Heroin Dependence/therapy , Humans , India/epidemiology , Male , Middle Aged , Young AdultABSTRACT
BACKGROUND: Despite the rise in heroin use in sub Saharan-Africa opioid agonist maintenance treatment (OAMT) is still not state-funded in South Africa and many other African countries. In South Africa there has been little data published on the profile of heroin users and the outcomes of treatment for those who attend public treatment services. METHODS: 300 heroin users from two state-funded rehabilitation centres in Johannesburg were studied at entry into rehabilitation and 3-months after treatment. Treatment consisted of inpatient detoxification and inpatient psychosocial rehabilitation. Structured interviews measured changes in drug use, psychopathology and criminality post rehabilitation. RESULTS: Most (65.7%) smoked heroin in combination with cannabis while 29.7% were injecting users. Almost half the sample (49.3%) had at least one mental illness. Of the 252 (84%) participants seen at 3-month follow-up, 6.3% were abstinent of all substances (excluding tobacco), 65.5% had continued heroin use (CHU) and the balance used other substances. At follow-up there were significant decreases in heroin use (p<0.0001) and criminality (p<0.0001). There were however significant increases in alcohol use (p<0.0001), crystalmetamphetamine use (p=0.032) and the prevalence of current episode of major depression (p<0.0001). Just 11.9% received formal psychosocial treatment after leaving rehabilitation. None were on OAMT and only three participants were on psychotropic medication. None were tested for Hepatitis C during the study period and the majority (53%) did not know their HIV status. CONCLUSION: There are significant gaps in current treatment services for heroin users in South Africa. Retention in treatment and assessment and management of psychiatric and non-psychiatric comorbidities is low. Services need to be more integrated and should also include the provision of OAMT.
Subject(s)
Heroin Dependence/epidemiology , Mental Disorders/epidemiology , Adult , Comorbidity , Depressive Disorder, Major/epidemiology , Female , Heroin Dependence/rehabilitation , Humans , Male , Prevalence , Prospective Studies , South Africa/epidemiology , Treatment Outcome , Young AdultABSTRACT
The main purpose of this study was to test the relationship between past-year suicide attempt (SA) and past-year opioid misuse among Veterans at high risk of suicide who reported using at least one illicit substance or alcohol in the past year. Baseline data from 130 high suicide-risk Veterans (nâ¯=â¯39 past-year opioid misusers; nâ¯=â¯91 past-year users of other substances) who enrolled in a randomized controlled trial testing adjunctive Mindfulness-Based Cognitive Therapy to Prevent Suicidal Behavior were used. Information was collected on a semi-structured interview that included the Columbia-Suicide Severity Rating Scale to collect suicide attempt history. Past-year opioid misusers, compared to those who used at least one other illicit substance or alcohol in the past year, were more likely to have made a past-year SA. Past-year opioid misuse remained associated with past-year SA in multivariate analysis that included other known risk factors for SA. Our findings show a robust link between near-term SA and opioid misuse in Veterans.
Subject(s)
Analgesics, Opioid , Opioid-Related Disorders/epidemiology , Prescription Drug Misuse/statistics & numerical data , Suicide, Attempted/statistics & numerical data , Suicide/statistics & numerical data , Veterans/statistics & numerical data , Adult , Aged , Alcohol Drinking/epidemiology , Cocaine-Related Disorders/epidemiology , Cognitive Behavioral Therapy , Depressive Disorder, Major/epidemiology , Female , Heroin Dependence/epidemiology , Humans , Male , Marijuana Use/epidemiology , Middle Aged , Mindfulness , Risk Factors , Suicidal Ideation , United States/epidemiology , Young Adult , Suicide PreventionABSTRACT
BACKGROUND AND AIMS: Between 2002 and 2014, past-month marijuana use among pregnant women in the United States increased 62%, nearly twice the growth of the general population. This growth coincides with the proliferation of state medical marijuana laws (MMLs) authorizing physicians to recommend marijuana for approved conditions. We estimated the association between MMLs and substance use treatment utilization among pregnant and non-pregnant women of reproductive age. We also examined whether the association varied across MML provisions, age groups and treatment referral sources to clarify potential pathways. DESIGN: Nation-wide administrative data from the 2002-14 Treatment Episodes Data Set Admissions, and a difference-in-differences design that exploited the staggered implementation of MMLs to compare changes in outcomes before and after implementation between MML and non-MML states. SETTING: Twenty-one MML and 27 non-MML US states. PARTICIPANTS: Pregnant and non-pregnant women aged 12-49 admitted to publicly funded specialty substance use treatment facilities. MEASUREMENTS: The primary outcome variable was the number of treatment admissions per 100 000 women aged 12-49, aggregated at the state-year level (n = 606). Admissions for marijuana, alcohol, cocaine and opioids were considered. The primary independent variable was an indicator of MML implementation in a state. FINDINGS: Among pregnant women, the rate of marijuana treatment admissions increased by 4.69 [95% confidence interval (CI) = 1.32, 8.06] in MML states relative to non-MML states. This growth was accompanied by increases in treatment admissions involving alcohol (ß = 3.19; 95% CI = 0.97, 5.410 and cocaine (ß = 2.56; 95% CI = 0.34, 4.79), was specific to adults (ß = 5.50; 95% CI = 1.52, 9.47) and was largest in states granting legal protection for marijuana dispensaries (ß = 6.37; 95% CI = -0.97, 13.70). There was no statistically significant association between MMLs and treatment admissions by non-pregnant women. CONCLUSIONS: Medical marijuana law implementation in US states has been associated with greater substance use treatment utilization by pregnant adult women, especially in states with legally protected dispensaries.
Subject(s)
Legislation, Drug/statistics & numerical data , Medical Marijuana , Pregnancy Complications/therapy , Substance-Related Disorders/therapy , Adolescent , Adult , Alcoholism/epidemiology , Alcoholism/therapy , Case-Control Studies , Child , Cocaine-Related Disorders/epidemiology , Cocaine-Related Disorders/therapy , Female , Heroin Dependence/epidemiology , Heroin Dependence/therapy , Humans , Marijuana Abuse/epidemiology , Marijuana Abuse/therapy , Middle Aged , Opioid-Related Disorders/epidemiology , Opioid-Related Disorders/therapy , Patient Admission , Pregnancy , Pregnancy Complications/epidemiology , Pregnant Women , Substance Abuse Treatment Centers , Substance-Related Disorders/epidemiology , Young AdultABSTRACT
BACKGROUND: Rates of both opioid and sedative use and misuse are rising. Comorbid opioid and sedative use is associated with especially severe consequences (e.g., overdose and poor health outcomes). Heroin users report multiple motivations for sedative use, including self-medication. We aimed to understand differences in lifetime substance use characteristics between heroin users with different sedative use histories. METHODS: Substance use data were collected from 385 non-treatment seeking heroin users. Subjects were divided into four lifetime sedative-use groups: no use, medical use only, non-medical use only, and mixed medical and non-medical use. We examined patterns of use of various substances of abuse (tobacco, alcohol, marijuana, cocaine, heroin, and sedatives) and individual characteristics associated with each. RESULTS: Non-medical sedative use (alone or in addition to medical use) was associated with more negative consequences from using all substances. Medical sedative use alone was not related to increased overdose or emergency room visits associated with heroin use. Non-medical sedative use was associated with increases in 15 of the 21 measured heroin consequences and only one of those - health problems - was also associated with medical sedative use. CONCLUSIONS: Concomitant non-medical sedative use and heroin use is associated with significantly greater negative outcomes than those experienced by heroin users who report use of sedatives only as prescribed. Understanding these differences offers insight into risks related to using both substances and may help treatment providers create targeted harm reduction interventions for this population.
Subject(s)
Analgesics, Opioid/therapeutic use , Drug Overdose/epidemiology , Heroin Dependence/epidemiology , Heroin , Hypnotics and Sedatives/therapeutic use , Substance-Related Disorders/epidemiology , Adolescent , Adult , Analgesics, Opioid/administration & dosage , Comorbidity , Female , Humans , Hypnotics and Sedatives/administration & dosage , Male , Mental Health , Middle Aged , Self Medication , Young AdultABSTRACT
AIMS: To analyse predictors of heroin abstinence in opiate substitution therapy (OST) based on frequency of crack use and its interactions with other predictors in a clinical non-experimental setting. DESIGN: Retrospective study. SETTING: A community drug service in London, UK. PARTICIPANTS: 325 clients starting OST between 2010 and 2014 (197 methadone and 128 buprenorphine). MEASUREMENTS: Logistic regression models (a general model and separate models for methadone and buprenorphine) assessed demographic and clinical data as predictors of heroin abstinence at one year after treatment start (or at the date of transfer to another service). FINDINGS: For the general model participants choosing methadone were more likely to use heroin at follow up (OR=2.36, 95% CI: 1.40-3.17) as were daily crack users on methadone (OR=2.62, 95% CI: 0.96-7.16). For the methadone model only daily crack use predicted heroin use at follow up (OR=2.62, 95% CI: 0.96-7.16). For buprenorphine, higher amounts of baseline heroin use, lower buprenorphine dose and daily drinking predicted heroin use at follow up (OR=0.85, 95% CI: 0.75-0.95; OR=1.31, 95% CI: 1.06-1.60 and OR=6.04, 95% CI: 1.26-28.92). Both use of cannabis and depression increased likelihood of heroin abstinence for clients not using crack compared to occasional (OR=6.68, 95% CI: 0.37-119.59; OR=106.31, 95% CI: 3.41-3313.30) and daily (OR=57.49 (95% CI: 2.37-1396.46; OR=170.99 (95% CI: 4.61-6339.47) users. CONCLUSIONS: Most of the predictors in the general model were found significant only in the buprenorphine but not in the methadone model, suggesting that a general model has little predictive value. Crack use was a significant predictor of heroin abstinence at follow up in all models, however for buprenorphine only when depression or cannabis use was present. Further research is needed to assess effective treatment approaches for the growing population of dual users.
Subject(s)
Buprenorphine/therapeutic use , Cocaine-Related Disorders/epidemiology , Heroin Dependence/epidemiology , Heroin Dependence/therapy , Methadone/therapeutic use , Opiate Substitution Treatment/methods , Adult , Aged , Analgesics, Opioid/therapeutic use , Comorbidity , Female , Humans , London/epidemiology , Male , Middle Aged , Narcotic Antagonists/therapeutic use , Retrospective Studies , Treatment Outcome , Young AdultABSTRACT
AIMS: To test if polysubstance use profiles and drug-related outcomes differ between those receiving and not receiving opioid substitution therapies (OST) among people who inject drugs (PWID). DESIGN: An annual cross-sectional, sentinel sample of PWID across Australia. SETTING: Data came from 3 years (2011-13) of the Illicit Drug Reporting System (IDRS). PARTICIPANTS: A total of 2673 participants who injected drugs from the combined national IDRS samples of 2011 (n = 868), 2012 (n = 922) and 2013 (n = 883). MEASUREMENTS: Latent class analysis (LCA) was used to summarize participants' self-reported use of 18 types of substances, with the resulting polysubstance use profiles then associated with participant experience of a number of drug-related outcomes. FINDINGS: Polysubstance use profiles exhibiting a broad range of substance use were generally at increased risk of negative drug-related outcomes, whether or not participants were receiving OST, including thrombosis among OST receivers [odds ratio (OR) = 2.13, 95% confidence intervals (CI) = 1.09-4.17], injecting with used needles among OST receivers and non-receivers, respectively (OR = 2.78, 95% CI = 1.50-5.13; OR = 2.15, 95% CI = 1.34-3.45) and violent criminal offences among OST receivers and non-receivers, respectively (OR =2.30, 95% CI = 1.16-4.58; OR = 1.87, 95% CI = 1.14-3.07). An important exception was non-fatal overdose which was related specifically to a class of PWID who were not receiving OST and used morphine frequently (OR = 1.83, 95% CI = 1.06-3.17) CONCLUSION: Regardless of opioid substitution therapies usage, people who inject drugs who use a broad-range of substances experience greater levels of injecting-related injuries and poorer health outcomes and are more likely to engage in criminal activity than other groups of people who inject drugs.
Subject(s)
Abscess/epidemiology , Analgesics, Opioid/therapeutic use , Drug Overdose/epidemiology , Needle Sharing/statistics & numerical data , Opiate Substitution Treatment , Opioid-Related Disorders/drug therapy , Substance Abuse, Intravenous/drug therapy , Thrombosis/epidemiology , Violence/statistics & numerical data , Adolescent , Adult , Alcoholism/epidemiology , Amphetamine-Related Disorders/epidemiology , Australia/epidemiology , Buprenorphine/therapeutic use , Buprenorphine, Naloxone Drug Combination/therapeutic use , Cocaine-Related Disorders/epidemiology , Cross-Sectional Studies , Female , Heroin Dependence/epidemiology , Humans , Male , Marijuana Abuse/epidemiology , Methadone/therapeutic use , Middle Aged , Odds Ratio , Opioid-Related Disorders/epidemiology , Substance-Related Disorders/epidemiology , Young AdultABSTRACT
AIMS: conduct needs assessments and treatment compliance evaluations in MMT and Suboxone Substitution State Programs in Georgia (Republic of). 506 patients (2 females) were surveyed (92% on Methadone, 8% on Suboxone) from 6 Tbilisi and 4 regional State Programs in 2011 November. Mean age - 40±8,56 (22-65) year; 254 (51.4%) were in treatment for 1-3 year. Evaluation was carried out on the base of structured self-questionnaire that covers demographics, drug use history, general drug use trends, psychotherapeutic sessions' acceptance and open label question regarding treatment challenges and satisfaction. 305 (60.3%) attended individual and 57 (11.3%) group psychotherapy sessions with 50.79% attending once/month or rare. The main reason given for therapy non-attendance - no needs for it (29.48%); the main drugs before admission - heroin (80.04%), buprenorphine (53.49%); Main drugs used in Georgia nowadays - desomorphine ("crocodile"), alcohol and marihuana. Commonly used drugs by program patients (136 positive answers) - alcohol-13.62%, marihuana-10.39%, pregabalin - 8.17%, opioids- 6.62% (mostly-"crocodile"), home-made stimulants-6.23%, sedatives -5.45%. 55.4% are extremely satisfied with treatment, 82.4% - with program staff. Patients' main wishes- free of charge programs (46.4%) and provide take-home doses (22.07%). Methadone and Suboxone ST are being well accepted in Georgia and appear to be reducing illegal opioid use. However, the psychotherapeutic sessions' attendance is very low.
Subject(s)
Opiate Substitution Treatment/methods , Patient Compliance , Substance-Related Disorders/drug therapy , Adult , Aged , Buprenorphine/therapeutic use , Buprenorphine, Naloxone Drug Combination , Female , Georgia (Republic)/epidemiology , Government Programs , Heroin Dependence/epidemiology , Humans , Hypnotics and Sedatives , Male , Marijuana Abuse/epidemiology , Methadone/therapeutic use , Middle Aged , Naloxone/therapeutic use , Needs Assessment , Patient Satisfaction , Psychotherapy , Substance-Related Disorders/epidemiology , Surveys and Questionnaires , Young AdultABSTRACT
Global health and conflict studies share key linkages that have important research and policy implications but for which data are currently lacking. This analytical review examines the ongoing conflict in Afghanistan, using it as a basis to develop a conceptual framework that integrates security and public health concepts. The analysis draws on recent peer-reviewed and gray literature to assess the interrelationship among 3 variable clusters and their impact on the emergence of the HIV epidemic in Afghanistan. The evidence suggests that there is a complex indirect relationship linking illicit opium trade, the ongoing insurgency, and forced and spontaneous migration to the emergence of an injection drug use-driven HIV epidemic in Afghanistan. These findings demonstrate a clear need for an integrated cross-disciplinary and regional approach to the emerging threat of HIV/AIDS in Afghanistan, to inform more balanced and effective policy making in this and other regions of strategic global import.
Subject(s)
Disease Outbreaks , HIV Infections/epidemiology , Opium/economics , Afghan Campaign 2001- , Afghanistan/epidemiology , Databases, Bibliographic , Heroin Dependence/epidemiology , Humans , Refugees/statistics & numerical data , Substance Abuse, Intravenous/epidemiologyABSTRACT
BACKGROUND: The GABRA2 gene has been implicated in addiction. Early life stress has been shown to alter GABRA2 expression in adult rodents. We hypothesized that childhood trauma, GABRA2 variation, and their interaction would influence addiction vulnerability. METHODS: African-American men were recruited for this study: 577 patients with lifetime DSM-IV single and comorbid diagnoses of alcohol, cocaine, and heroin dependence, and 255 control subjects. The Childhood Trauma Questionnaire (CTQ) was administered. Ten GABRA2 haplotype-tagging single-nucleotide polymorphisms (SNPs) were genotyped. RESULTS: We found that exposure to childhood trauma predicted substance dependence (p < .0001). Polysubstance dependence was associated with the highest CTQ scores (p < .0001). The African Americans had four common haplotypes (frequency: .11-.30) within the distal haplotype block: two that correspond to the Caucasian and Asian yin-yang haplotypes, and two not found in other ethnic groups. One of the unique haplotypes predicted heroin addiction, whereas the other haplotype was more common in control subjects and seemed to confer resilience to addiction after exposure to severe childhood trauma. The yin-yang haplotypes had no effects. Moreover, the intron 2 SNP rs11503014, not located in any haplotype block and potentially implicated in exon splicing, was independently associated with addiction, specifically heroin addiction (p < .005). Childhood trauma interacted with rs11503014 variation to influence addiction vulnerability, particularly to cocaine (p < .005). CONCLUSIONS: Our results suggest that at least in African-American men, childhood trauma, GABRA2 variation, and their interaction play a role in risk-resilience for substance dependence.
Subject(s)
Adult Survivors of Child Abuse/psychology , Genetic Predisposition to Disease , Polymorphism, Single Nucleotide/genetics , Receptors, GABA-A/genetics , Substance-Related Disorders/genetics , Adult , Black or African American , Alcoholism/epidemiology , Alcoholism/genetics , Chi-Square Distribution , Cocaine-Related Disorders/epidemiology , Cocaine-Related Disorders/genetics , Databases, Factual/statistics & numerical data , Environment , Exons/genetics , Gene Frequency , Genotype , Heroin Dependence/epidemiology , Heroin Dependence/genetics , Humans , Incidence , Male , Middle Aged , Statistics as Topic , Substance-Related Disorders/epidemiology , Surveys and QuestionnairesABSTRACT
Heroin users are at high risk for HIV infection, but little is known about HIV risk in oxycodone users. This study examined HIV risk behaviors in heroin (n = 27) and oxycodone (n = 23) users seeking inpatient detoxification at a private psychiatric hospital. Drug use histories were similar, except oxycodone users used marijuana more frequently. Injection drug risk occurred exclusively among heroin users. The rates of sexual activity (66%), unprotected intercourse (69%), sex while intoxicated (74%), and sex with strangers (24%) were similar, but more oxycodone users had multiple partners (39% vs. 6%, p < .05). HIV prevention efforts should target both heroin and oxycodone users.
Subject(s)
HIV Infections/epidemiology , Inactivation, Metabolic , Narcotics , Opioid-Related Disorders/epidemiology , Opioid-Related Disorders/rehabilitation , Oxycodone , Patient Acceptance of Health Care/statistics & numerical data , Risk-Taking , Adolescent , Adult , Female , HIV Infections/prevention & control , Heroin Dependence/epidemiology , Heroin Dependence/rehabilitation , Hospitalization , Humans , Male , Marijuana Abuse/epidemiology , Marijuana Abuse/rehabilitation , Middle Aged , Prevalence , Severity of Illness Index , Sexual Partners , Unsafe Sex , Young AdultABSTRACT
Major opium trafficking routes traverse rural Iran, but patterns of drug use and HIV infection in these areas are unknown. In 2004, Iran's Ministry of Health integrated substance use treatment and HIV prevention into the rural primary health care system. Active opium or heroin users (N = 478) were enrolled in a rural clinic. Participants received counseling for abstinence from substances, or daily needle exchange and condoms. On enrollment, 108 (23%) reported injecting; of these, 79 (73%) reported sharing needles. Of 65 participants tested for HIV, 46 (72%) tested positive. Participants who received daily needle exchange/condoms stayed in the program longer than those who did not (AOR 2.08, 95% CI 1.1-3.88). This project demonstrates that HIV risks exist in rural Iran and suggests the innovative use of Iran's rural health care system to extend prevention and treatment services to these populations.
Subject(s)
HIV Infections/prevention & control , Program Evaluation , Rural Population , Substance Abuse, Intravenous/epidemiology , Substance Abuse, Intravenous/prevention & control , Adult , Condoms/statistics & numerical data , Delivery of Health Care , Female , HIV Infections/epidemiology , Harm Reduction , Heroin Dependence/complications , Heroin Dependence/epidemiology , Heroin Dependence/prevention & control , Humans , Iran/epidemiology , Male , Middle Aged , Needle Sharing , Needle-Exchange Programs , Opioid-Related Disorders/complications , Opioid-Related Disorders/epidemiology , Opioid-Related Disorders/prevention & control , Opium , Primary Health Care , Risk Assessment , Substance Abuse, Intravenous/complicationsABSTRACT
AIM: This study describes temporal changes of the pattern of substance abuse among drug users in treatment in Lazio, Italy. METHODS: We used individual data from the surveillance system of drug users of the Lazio region. We measured temporal changes in: the number of drug users in treatment, main and any substance of abuse, and mode of referral to treatment. RESULTS: Among new clients, the proportion of heroin use decreased from 78.2% in 1996 to 37.6% in 2003 (p < 0.0001), while cocaine use increased from 4.1% in 1996 to 30.1% in 2003 (p < 0.0001). In 2003, any use of cocaine was reported by 43.1% of new cases as compared to 38.9% taking heroin, 36.8% cannabis and 5.3% other substances, 41.9% using more than one substance. In 2003, 37.7% of new patients were referred to treatment by the police as compared to 10.4% in 1996. CONCLUSIONS: Heroin use has been replaced by cocaine among people coming to treatment centres for the first time. The main mode of access to treatment of new cocaine and cannabis users occurred through mandatory referral by the police. Routine surveillance systems of treatment demand are essential to monitor temporal trends of patterns of drug use in order to plan proper treatment strategies.
Subject(s)
Patient Admission/trends , Substance-Related Disorders/epidemiology , Adolescent , Adult , Cocaine-Related Disorders/epidemiology , Cross-Sectional Studies , Female , Health Services Needs and Demand/trends , Health Surveys , Heroin Dependence/epidemiology , Humans , Incidence , Italy , Male , Marijuana Abuse/epidemiology , Middle Aged , Referral and Consultation/trendsABSTRACT
In recent years, controversial interventions such as 'heroin-assisted treatment' (HAT) and 'supervised injection facilities' (SIFs) have been established in attempts to minimise the high morbidity and mortality consequences of illicit drug use. This paper examines public opinion towards HAT and SIF using data from the 2003 Centre for Addiction and Mental Health (CAMH) Monitor, a representative population survey conducted among adults residing in Ontario, Canada. Data relating specifically to SIFs and HAT were isolated from the main database (n=885); agreement scores were collapsed to create a scale and analysed using independent sample t-tests and ANOVAs. Results revealed that 60 percent (n=530) of the sample agreed that SIFs should be made available to injection drug users, while 40 percent (n=355) disagreed. When asked about the provision of HAT, a similar pattern emerged. Variables significantly associated with positive opinions toward SIFs and HAT were: income; higher education; the use of cocaine or cannabis within the last 12 months; being in favour of cannabis decriminalisation; support of needle exchange in prison; view of illicit drug users as ill people; and agreement that drug users are in need of public support. Given the current political climate and the tentative position of SIFs and HAT in Canada, understanding the public's opinion is crucial for the feasibility and long-term sustainability of these interventions.
Subject(s)
Heroin Dependence , Substance Abuse Treatment Centers/methods , Adult , Aged , Aged, 80 and over , Educational Status , Female , Harm Reduction , Heroin Dependence/epidemiology , Heroin Dependence/rehabilitation , Humans , Interviews as Topic , Male , Middle Aged , Ontario/epidemiology , Public Facilities/legislation & jurisprudence , Public Opinion , Public Policy , Socioeconomic Factors , Substance Abuse, Intravenous/rehabilitationABSTRACT
The prevalence of zopiclone misuse in clients attending a methadone maintenance programme in Dublin through detection of its degradation product, 2-amino-5-chloropyridine (ACP) on urinalysis is outlined. Urine samples from all 158 clients were tested for the presence of ACP, opiates, benzodiazepines, cocaine, alcohol and cannabis. Of the 37 (23%) clients who tested positive for ACP, 23 (62%) were interviewed. A profile of zopiclone misusers is outlined, including details of demographics, drug history, viral status, recent urinalysis results and opinions on zopiclone. Of the 14 (38%) clients who were not interviewed, information was obtained from their clinical casenotes and documented urinalysis results. The prevalence of zopiclone misuse was reported as 23%. Benzodiazepines were the most popular drug of misuse with zopiclone followed by heroin/opiates. Zopiclone is being misused by drug users in Dublin in the context of many other drugs. Prescribing of zopiclone should be restricted, especially among drug misusers.
Subject(s)
Methadone/therapeutic use , Narcotics/therapeutic use , Opioid-Related Disorders/epidemiology , Piperazines , Substance-Related Disorders/epidemiology , Adult , Azabicyclo Compounds , Benzodiazepines , Comorbidity , Cross-Sectional Studies , Female , Hepatitis C/epidemiology , Heroin Dependence/epidemiology , Heroin Dependence/rehabilitation , Humans , Ireland , Male , Opioid-Related Disorders/rehabilitation , Pyridines/urine , Substance Abuse Detection , Substance Abuse, Intravenous/epidemiology , Substance Abuse, Intravenous/rehabilitation , Substance-Related Disorders/rehabilitationABSTRACT
INTRODUCTION: The global epidemic of opiate use continues to spread and is an increasing burden especially in developing countries. Acute opiate overdose (AOO) is one of the most dramatic complications of drug abuse. The purpose of this study is to examine the epidemiology of acute opiate overdose in a poisoning center in Tehran. METHODS: In this cross-sectional survey, patients who attended the emergency room of Loghman-Hakim hospital - the only poisoning center in Tehran - and diagnosed with acute opiate overdose over a six month period were included. RESULTS: Overdose was more common among men (91.2%). The mean and standard deviation of age was 36.9+/-15. The most frequent opiate agent was opium (56.5%) followed by heroin. Opium was most commonly used by regular users, as a single agent and through ingestion. Benzodiazepines, antidepressants and alcohol were the most common agents consumed accompanied with opiates. The mortality rate was 8.8% which was not significantly different between cases of heroin and opium overdose. CONCLUSION: Opium was the major cause of overdose in our study. This result suggests that opium is not a harmless form of addiction although it is regarded as a thing of the past in many countries.
Subject(s)
Opioid-Related Disorders/epidemiology , Opioid-Related Disorders/rehabilitation , Opium/adverse effects , Acute Disease , Adult , Catchment Area, Health , Cross-Sectional Studies , Drug Overdose , Heroin Dependence/epidemiology , Heroin Dependence/rehabilitation , Hospitalization , Humans , Iran/epidemiology , Male , Poison Control Centers , Prevalence , Surveys and QuestionnairesABSTRACT
OBJECTIVE: This study examined the outcomes of individuals with co-occurring disorders who received drug treatment in programs that varied in their integration of mental health services. Patients treated in programs that provided more on-site mental health services and had staff with specialized training were expected to report less substance use and better psychological outcomes at follow-up. METHODS: Participants with co-occurring disorders were sampled from 11 residential drug abuse treatment programs for adults in Los Angeles County. In-depth assessments of 351 patients were conducted at treatment entry and at follow-up six months later. Surveys conducted with program administrators provided information on program characteristics. Latent variable structural equation models revealed relationships of patient characteristics and program services with drug use and psychological functioning at follow-up. RESULTS: Individuals treated in programs that provided specific dual diagnosis services subsequently had higher rates of utilizing mental health services over six months and, in turn, showed significantly greater improvements in psychological functioning (as measured by the Brief Symptom Inventory and the RAND Health Survey 36-item short form) at follow-up. More use of psychological services was also associated with less heroin use at follow-up. African Americans reported poorer levels of psychological functioning than others at both time points and were less likely to be treated in programs that provided mental health services. CONCLUSIONS: Study findings support continued efforts to provide specialized services for individuals with co-occurring disorders within substance abuse treatment programs as well as the need to address additional barriers to obtaining these services among African Americans.